Nuveen Asset Management, LLC Spruce Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.23 $14,903 - $25,963	-11,643 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.74 $26,503 - $65,292	-11,375 Reduced 49.42%	11,643 $29,000
Q3 2021 Nov 12, 2021	SELL	$6.01 - $11.26 $39,653 - $74,293	-6,598 Reduced 22.28%	23,018 $164,000
Q2 2021 Aug 16, 2021	BUY	$10.12 - $17.46 $184,123 - $317,667	18,194 Added 159.29%	29,616 $332,000
Q1 2021 May 17, 2021	SELL	$14.8 - $25.79 $166,411 - $289,982	-11,244 Reduced 49.61%	11,422 $190,000
Q4 2020 Feb 16, 2021	BUY	$15.38 - $32.42 $348,603 - $734,831	22,666 New	22,666 $551,000

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.66M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.